NSAIDs could pose erectile dysfunction risk among men
PASADENA, Calif. — Long-term use of a class of drugs used to control pain could increase the risk of erectile dysfunction in men, according to a new study.
The study, sponsored by Kaiser Permanente and published online in the Journal of Urology, found that men who took nonsteroidal anti-inflammatory drugs, or NSAIDs, three times a day for more than three months were 2.4 times as likely to have erectile dysfunction as men who didn’t take the drugs regularly. The study used data from 80,966 men ages 45 to 69 years in California.
After controlling for such factors as age, race, ethnicity, smoking, diabetes and cardiovascular disease, the researchers found the risk was 1.4 times as high in regular users of NSAIDs.
“We went into this study thinking we would find the opposite effect: that NSAIDs would have a protective effect because they protect against heart disease, which is also linked to [erectile dysfunction],” study senior author Steven Jacobsen said. “The next step is to dive a bit deeper to understand the underlying physiology of what might be happening with these drugs.”
ECRM presents awards to three suppliers
ORLANDO, Fla. — ECRM on Wednesday evening announced the Vendor Award recipients for its ECRM Cough & Cold and Allergy event held here, recognizing GOJO Industries for the “Most Prepared,” the Emerson Group for “Best Room” and Cobalis for “Best New Product.”
The awards, sponsored by The Drug Store News Group, represent a tally of retail buyer votes on each of the categories.
GOJO Industries is preparing to relaunch its Purell hand sanitizer business after acquiring that brand back from Johnson & Johnson last year. Under the direction of sales VP Tim Cleary, GOJO’s team of seven sales representatives showcased for buyers the Purell brand heritage and how the company plans to better position the brand in the coming months and years.
The Emerson Group showcased its host of client companies, including Similasan, Fleming Pharmaceuticals and Dynova Labs, among others, in a grand ballroom sporting a "winter wonderland" theme.
Cobalis was recognized for its introduction of PreHistin, a supplement ideal for allergy sufferers as it helps regulate the function of histamines. The new product is available as a quick-dissolve cherry lozenge.
Dulcolax, CCA encourage consumers to get screened for colon cancer
RIDGEFIELD, Conn. — Dulcolax has teamed up with the Colon Cancer Alliance and American fashion designer Carmen Marc Valvo to encourage men and women to be proactive about their colon health by getting a colonoscopy.
According to a new survey conducted on behalf of Boehringer Ingelheim, the makers of Dulcolax, and the CCA, more than a quarter (27%) of respondents ages 50 years and older have not had a colonoscopy, a colon cancer screening test, with the most often-cited reason being that they do not have a family history of colon cancer. What’s more, 60% of those respondents said they would be more concerned about the preparation than the actual procedure. Valvo, who was diagnosed with colon cancer eight years ago, said the benefits of a colon cancer screening outweighed the discomfort.
"I certainly understand why people are hesitant to be examined, but the fact is, it’s not nearly as uncomfortable as you might imagine, and any discomfort from the screening is surely outweighed by the benefits of preventing cancer from developing or catching it in its early stages," Valvo said. Valvo now is cancer-free.
As part of its support of colon cancer screenings, Boehringer Ingelheim noted that a portion of proceeds from the purchase of Dulcolax supports free colon cancer screenings for those in need.